Ossiam Abb Vie Inc. Transaction History

Ossiam

$5.1 Billion
Q3 2024

A detailed history of Ossiam transactions in Abb Vie Inc. stock. As of the latest transaction made, Ossiam holds 305,088 shares of ABBV stock, worth $54.4 Million. This represents 1.18% of its overall portfolio holdings.

Number of Shares

305,088

Previous 58,372 422.66%

Holding current value

$54.4 Million

Previous $10 Million 501.82%

% of portfolio

1.18%

Previous 0.19%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$163.84 - $199.33 $40.4 Million - $49.2 Million	246,716 Added 422.66%	305,088 $60.2 Million
Q2 2024 Aug 13, 2024	SELL	$154.79 - $180.76 $46,591 - $54,408	-301 Reduced 0.51%	58,372 $10 Million
Q1 2024 May 13, 2024	SELL	$159.82 - $182.1 $84,864 - $96,695	-531 Reduced 0.9%	58,673 $10.7 Million
Q4 2023 Feb 13, 2024	BUY	$137.6 - $154.97 $859,036 - $967,477	6,243 Added 11.79%	59,204 $9.17 Million
Q3 2023 Nov 14, 2023	BUY	$133.59 - $154.65 $2.4 Million - $2.77 Million	17,934 Added 51.2%	52,961 $7.89 Million
Q2 2023 Aug 11, 2023	SELL	$132.51 - $164.9 $361,884 - $450,341	-2,731 Reduced 7.23%	35,027 $4.72 Million
Q1 2023 May 12, 2023	SELL	$144.61 - $166.54 $451,761 - $520,270	-3,124 Reduced 7.64%	37,758 $6.02 Million
Q4 2022 Feb 13, 2023	SELL	$138.31 - $165.87 $18.8 Million - $22.6 Million	-136,143 Reduced 76.91%	40,882 $6.61 Million
Q3 2022 Nov 14, 2022	BUY	$134.21 - $153.93 $2.67 Million - $3.06 Million	19,885 Added 12.65%	177,025 $23.8 Million
Q2 2022 Aug 12, 2022	SELL	$137.62 - $174.96 $18.4 Million - $23.3 Million	-133,452 Reduced 45.92%	157,140 $24.1 Million
Q1 2022 May 13, 2022	SELL	$131.98 - $163.75 $9.47 Million - $11.8 Million	-71,779 Reduced 19.81%	290,592 $47.1 Million
Q4 2021 Feb 14, 2022	BUY	$107.43 - $135.93 $23.9 Million - $30.3 Million	222,572 Added 159.21%	362,371 $49.1 Million
Q3 2021 Nov 12, 2021	SELL	$106.4 - $120.78 $1.12 Million - $1.27 Million	-10,526 Reduced 7.0%	139,799 $15.1 Million
Q2 2021 Aug 13, 2021	SELL	$105.21 - $117.21 $17.3 Million - $19.3 Million	-164,871 Reduced 52.31%	150,325 $17.5 Million
Q1 2021 May 17, 2021	BUY	$102.3 - $112.62 $20.7 Million - $22.8 Million	202,136 Added 178.79%	315,196 $34.1 Million
Q4 2020 Feb 12, 2021	SELL	$80.49 - $108.67 $260,948 - $352,308	-3,242 Reduced 2.79%	113,060 $12.1 Million
Q3 2020 Nov 12, 2020	BUY	$85.91 - $100.83 $7.1 Million - $8.34 Million	82,665 Added 245.76%	116,302 $10.2 Million
Q2 2020 Aug 13, 2020	BUY	$73.37 - $98.18 $62,364 - $83,453	850 Added 2.59%	33,637 $3.3 Million
Q1 2020 May 14, 2020	BUY	$64.5 - $97.79 $1.99 Million - $3.02 Million	30,845 Added 1588.31%	32,787 $2.5 Million
Q4 2019 Feb 14, 2020	SELL	$72.13 - $90.25 $1.75 Million - $2.19 Million	-24,246 Reduced 92.58%	1,942 $172,000
Q3 2019 Nov 13, 2019	BUY	$62.98 - $75.72 $1.58 Million - $1.9 Million	25,114 Added 2338.36%	26,188 $1.98 Million
Q2 2019 Aug 13, 2019	BUY	$65.7 - $83.98 $70,561 - $90,194	1,074 New	1,074 $78,000
Q1 2019 May 15, 2019	SELL	$77.14 - $90.79 $578,935 - $681,378	-7,505 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$77.85 - $96.01 $584,264 - $720,555	7,505 New	7,505 $692,000

Others Institutions Holding ABBV

# of Institutions

3,853

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $315B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ossiam, based on Form 13F filings with the SEC.

News

Stay updated on Ossiam with notifications on news.

Account